Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2019 13:53 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Inc. Reports Revenues Up 850% for Q2

OCEANSIDE, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Therapeutics Solutions International Inc. (OTC: TSOI) today reports that its second-quarter 2019 revenues increased 850%, as...
August 26, 2019 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients

OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
July 29, 2019 09:00 ET | Source: Therapeutic Solutions International, Inc.

NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer

OCEANSIDE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal data demonstrating synergy at...
July 22, 2019 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer

OCEANSIDE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) reported today positive animal data demonstrating synergy...
May 09, 2018 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi, MD, to Science Board

Company to Initiate Investigational Cardiovascular Study with Dr. Azimi and NanoStilbene OCEANSIDE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International,...
May 01, 2018 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers

Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform withPatented Augmenter of Cancer Immunotherapy NanoStilbene OCEANSIDE, Calif., May 01, 2018 ...